Profound Medical Corp Stock Today
| PRN Stock | CAD 11.44 0.57 5.24% |
Performance0 of 100
| Odds Of DistressLess than 19
|
Profound Medical is selling at 11.44 as of the 30th of November 2024; that is 5.24% increase since the beginning of the trading day. The stock's open price was 10.87. Profound Medical has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Profound Medical Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. The company has 24.66 M outstanding shares of which 76.41 K shares are at this time shorted by private and institutional investors with about 10.9 days to cover all short positions. More on Profound Medical Corp
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Profound Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Profound Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Profound Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | ||||
Profound Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Profound Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsProfound Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Profound Medical's financial leverage. It provides some insight into what part of Profound Medical's total assets is financed by creditors.
| |||||
Profound Medical Corp (PRN) is traded on Toronto Exchange in Canada and employs 131 people. Profound Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 282.13 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Profound Medical's market, we take the total number of its shares issued and multiply it by Profound Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Profound Medical Corp operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 24.66 M outstanding shares of which 76.41 K shares are at this time shorted by private and institutional investors with about 10.9 days to cover all short positions.
Profound Medical Corp has accumulated about 27.05 M in cash with (22.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Check Profound Medical Probability Of Bankruptcy
Ownership AllocationProfound Medical owns a total of 24.66 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Profound Ownership Details
Profound Medical Corp Risk Profiles
Although Profound Medical's alpha and beta are two of the key measurements used to evaluate Profound Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.02 | |||
| Standard Deviation | 2.89 | |||
| Variance | 8.37 | |||
| Risk Adjusted Performance | (0.01) |
Profound Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Profound Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Profound Medical Corporate Management
Elected by the shareholders, the Profound Medical's board of directors comprises two types of representatives: Profound Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Profound. The board's role is to monitor Profound Medical's management team and ensure that shareholders' interests are well served. Profound Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Profound Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.